Horizon Pharma to acquire Raptor Pharmaceuticals

Sept 12 (Reuters) - Horizon Pharma Plc said it has

agreed to buy Raptor Pharmaceutical Corp for nearly

$800 Million to expand its business in the rare diseases

treatment market.

Read more